font>

|
| ||||||||||||||||||||||||||||||||||||||
| Sort by relevance Sorted by date |
Singh song plays well for New Look
Guardian, UK - Aug 1, 2003
... generic drugs manufacturer Apotex announced it had received final regulatory approval
in the US to launch a copycat version of GSK's antidepressant pill Paxil. ...
Footsie suffers on GSK drug worries
The Scotsman, UK - Aug 1, 2003
... Earlier Apotex, a privately held drugmaker, said it had received final US regulatory
approval to market a generic version of Glaxo’s anti-depressant Paxil. ...
FDA Statement Regarding the Anti-Depressant Paxil for Pediatric ...
Doctor's Guide, NY - Aug 1, 2003
... reports of a possible increased risk of suicidal thinking and suicide attempts in
children and adolescents under the age of 18 treated with the drug Paxil for ...
FTSE sags on doubts over economy; Glaxo, banks dip
Forbes - Aug 1, 2003
... Earlier Apotex, a privately held drugmaker, said it received final US regulatory
approval to market a generic version of Glaxo's anti-depressant Paxil. ...
FTSE sags on doubts over economy; Glaxo, banks dip
Reuters, UK - Aug 1, 2003
... Earlier Apotex, a privately held drugmaker, said it received final US regulatory
approval to market a generic version of Glaxo's anti-depressant Paxil. ...
European Stocks Drop, Led by Lloyds TSB; Societe Generale Rises
Bloomberg - Aug 1, 2003
... won the first US Food and Drug Administration approval to sell a generic
version of Glaxo's best- selling product, the antidepressant Paxil. ...
Daily Briefing
Atlanta Journal Constitution, GA - Aug 1, 2003
... won the first US Food and Drug Administration approval to sell a generic version
of GlaxoSmithKline PLC's best-selling product, the antidepressant Paxil. ...
The day terror came to church
Edmonton Sun, Canada - Aug 1, 2003
... The toolmaker said he'd been off the anti-depressant drug Paxil and another prescribed
drug to combat his "shyness" for several days before the robbery. ...
Sell-off talk puts bounce into JJB
This is London, UK - Aug 1, 2003
... Apotex Corporation received US Food and Drug Administration approval
to market a generic version of GSK's antidepressant Paxil. ...
US Generic Competition Nears on Glaxo Drugs
Reuters, UK - Jul 31, 2003
Apotex Corp., a privately held drugmaker, said it received final US regulatory
approval to market a generic version of Glaxo's antidepressant Paxil, which ...
Gloomy view adds to Sainsbury's woes
The Times, UK - Jul 31, 2003
... pondered the announcement that the US Food and Drug Administration had approved
the application of Canada’s Apotex to make a generic version of Paxil, its ...
Apotex: FDA OKs generic Paxil
South Florida Business Journal, FL - Jul 31, 2003
The Weston-based US subsidiary of Canadian drug maker Apotex said the US
Food and Drug Administration has cleared it to sell generic Paxil. ...
Apotex gets approval for generic Paxil
Forbes - Jul 31, 2003
... a privately held drugmaker, said on Thursday it received final US regulatory approval
to market a generic version of GlaxoSmithKline's antidepressant Paxil ...
Business Editors/Health/Medical Writers
Business Wire (press release) - Jul 31, 2003
... the company's Abbreviated New Drug Application (ANDA) for paroxetine hydrochloride
tablets, 10mg, 20mg, 30mg and 40mg, AB rated to GlaxoSmithKline's (GSK) Paxil ...
Patents, research keep costs high
Lorain Morning Journal, OH - Jul 31, 2003
... direct to consumers in 2000 all became blockbusters in 2001: Vioxx, Zocor, heartburn
reliever Prilosec, allergy reliever Claritin and anti-depressant Paxil. ...
Patents, research keep costs high
Lorain Morning Journal, OH - Jul 31, 2003
... direct to consumers in 2000 all became blockbusters in 2001: Vioxx, Zocor, heartburn
reliever Prilosec, allergy reliever Claritin and anti-depressant Paxil. ...
COOK GETS LIFE FOR KILLING MOM, DAUGHTER
The Southern Illinoisan, IL - Jul 30, 2003
... Cook said he is taking prescription medication, including Paxil, but that the drugs
make him "think more clearly." Cook persisted in telling the court that he ...
Business brings Canadian drugs to TN
WKRN, TN - Jul 29, 2003
... 100 pills of Paxil, at a 20 milligram dosage, will cost you $337.99 at Walgreens
and $289.39 at Eckerd. Canadian Drugs 2 U sells it for $169.93. ...
Emerson tells group Medicare is the issue that 'riles me up'
Kennett Daily Dunklin Democrat, MO - Jul 29, 2003
... each medication listed. Some of the medications listed were Augmentin,
Claritin, Paxil, Prilosec, and Zocor. The largest savings ...
Paxil - Is It Safe for Children ?
Yahoo News (press release) - Jul 29, 2003
... NY, July 29 /PRNewswire/ -- The UK's Committee on Safety of Medicines recently issued
a "Dear Colleague" letter advising physicians not to use paroxetine (Paxil ...
Symptom of a problem
Raleigh News, NC - Jul 29, 2003
... London-based GSK, whose products include the asthma drug Advair and the antidepressant
Paxil, has one of its two US headquarters in Research Triangle Park. ...
Major changes on regulatory framework unlikely until Chrétien ...
Hill Times, Canada - Jul 28, 2003
... and Health seem to think, in general, that the current system is working well,
but there are complaints about the big blockbuster drugs like Losec and Paxil ...
Medication Delivered to Nasiriah The Freedom and Peace Trust
Feature Xpress (press release) - Jul 28, 2003
... The balance of the psychotropic drugs included in the above shipment containing
Risperdal, Paxil and Phenytoin, is being distributed to Al-Rashad Mental ...
Clinic studies new medications
Carlisle Sentinel, PA - Jul 28, 2003
... She also asks about any prescription medications — for example, selected serotonin
reuptake inhibitors such as Paxil or Zoloft interfere with the effects of ...
ANTIDEPRESSANTS MAY HAVE DRIVEN KILLER'S RAGE
Yahoo News - Jul 27, 2003
... bit odd. But now some folks are wondering if the antidepressant drug
Paxil turned him into a coldblooded killing machine. The Food ...
Preemptive Strike
Washington Post, DC - Jul 26, 2003
... Concerned at one point that he might be getting seriously depressed, he visited
the embassy doctor and came away with a box of Paxil that he eventually ...
Who's a Hero Now?
New York Times - Jul 26, 2003
... Like many of the miners, Mayhugh has been seeing a therapist once a week
ever since the rescue. He's also on Paxil, an antidepressant. ...
ANTIDEPRESSANTS MAY HAVE DRIVEN KILLER'S RAGE
Yahoo News - Jul 26, 2003
... bit odd. But now some folks are wondering if the antidepressant drug
Paxil turned him into a coldblooded killing machine. The Food ...
ANTIDEPRESSANTS MAY HAVE DRIVEN KILLER'S RAGE
Yahoo News - Jul 26, 2003
... bit odd. But now some folks are wondering if the antidepressant drug
Paxil turned him into a coldblooded killing machine. The Food ...
ANTIDEPRESSANTS MAY HAVE DRIVEN KILLER'S RAGE
New York Post, NY - Jul 26, 2003
... bit odd. But now some folks are wondering if the antidepressant drug
Paxil turned him into a coldblooded killing machine. The Food ...
Making Money At The Molecular Level
Forbes - Jul 25, 2003
... London-based Skye developed a sustained-release version of GlaxoSmithKline's
(nyse: GSK - news - people ) Paxil, a treatment for depression. ...
Making Money At The Molecular Level
Forbes - Jul 25, 2003
... London-based Skye developed a sustained-release version of GlaxoSmithKline's
(nyse: GSK - news - people ) Paxil, a treatment for depression. ...
Mind the Gap
Forbes - Jul 25, 2003
... the years running up to the deal the companies' laboratories had failed to come up
with new drugs to replace the household names--Augmentin (antibiotic), Paxil ...
HIV ASSASSIN WAS FUELED BY FEAR OF 'GAY' BLACKMAIL
New York Post, NY - Jul 24, 2003
... positive. They said they found prescriptions for Paxil, Zarret and Viagra,
as well as gay porn and sadomasochistic material. Investigators ...
Combustible Mix Behind City Hall Shooting
New York Times - Jul 24, 2003
... say that Mr. Askew did not have a history of psychiatric hospitalizations but
that he did, in his Brooklyn house, have prescriptions for Valium and Paxil ...
Coming out at 13
The Advocate - Jul 24, 2003
... from Twin Peaks, which I would guess he has played enough times over the past three
months to force the neighbors to install soundproof glass and go on Paxil. ...
GlaxoSmithKline's quarterly profit rises
Seattle Post Intelligencer, WA - Jul 24, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Rolling the Rx Highway
Tech Central Station - Jul 24, 2003
... Similarly, a 44 year-old female with anxiety disorder and panic attack needs time-released
Paxil. It's not approved in Canada , so she's boarded the bus, too. ...
Top pay row is bad for business, admits Glaxo
Guardian, UK - Jul 23, 2003
... This is an improvement on its previous guidance which had contained a caveat about
the impact of competition on its anti-depressant drug Paxil in the United ...
GSK upbeat after profits soar to £3.55bn
The Scotsman, UK - Jul 23, 2003
... The company said it was now predicting high single-digit earnings growth or better,
regardless of possible generic competition to its anti-depressant Paxil in ...
Running to stand still is not good enough
The Scotsman, UK - Jul 23, 2003
... GSK’s prediction that it will achieve high single digit earnings growth in 2003
irrespective of possible generic competition to its key anti-depressant Paxil ...
I'm at bottom of pay pile, claims Glaxo chief
Telegraph.co.uk, UK - Jul 23, 2003
... its earnings per share growth guidance to high single digit growth or better, regardless
of possible generic competition to blockbuster antidepressant Paxil in ...
Glaxo posts higher profit despite lower revenue
Raleigh Triangle Business Journal, NC - Jul 23, 2003
... will post earnings per share growth in the high single digits or higher in 2003 regardless
of generic competition to its hugely successful antidepressant Paxil ...
Slower sales fail to curb GSK profits
The Times, UK - Jul 23, 2003
... pointed to a rise of 9per cent in earnings in the second quarter and promised as
good or better for the full year, regardless of generic competition to Paxil ...
Glaxo Q2 net up 9%, eyes better '03
Economic Times, India - Jul 23, 2003
... 03 guidance, predicting high single-digit EPS growth or better, excluding currency
effects, regardless of possible generic competition to antidepressant Paxil ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update4)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
GlaxoSmithKline on a high
News24, South Africa - Jul 23, 2003
... competition for its products, saying its annual earnings would shine regardless of
whether generics swamped sales of its star performer anti-depressant Paxil. ...
Drug developer GlaxoSmithKline's quarterly profit rises 13 per ...
Waterloo Record, Canada - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Doctors should be wary of Paxil
CBC Saskatchewan, Canada - Jul 23, 2003
SASKATOON - The makers of the popular antidepressant Paxil recently
admitted the drug is not safe for children. Studies have shown ...
UPDATE 2-Drugmakers sales slow down due to rival medicines
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Big Drugmakers Lose Sales to Rivals
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Big Drugmakers Lose Sales to Rivals
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline's Quarterly Profit Rises
Springfield News Sun, OH - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Big Drugmakers Losing Sales to Rivals
FOX News - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
CORRECTED - Drugmakers sales slow down due to rival medicines
Forbes - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Drugmakers sales slow down due to rival medicines
Forbes - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update3)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
CORRECTED - Drugmakers sales slow down due to rival medicines
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline's Quarterly Profit Rises
Atlanta Journal Constitution, GA - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Austin American Statesman, TX - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Drug developer GlaxoSmithKline's quarterly profit rises 13 per ...
Canada.com, Canada - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
San Jose Mercury News, CA - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Newsday - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Big Drugmakers Losing Sales to Rivals
Washington Post, DC - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline's quarterly profit rises
Penn Live, PA - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Kansas City Star, MO - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Times Daily, AL - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Fort Wayne News Sentinel, IN - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Drugmakers sales slow down due to rival medicines
Forbes - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline's Quarterly Profit Rises
Miami Herald, FL - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
GlaxoSmithKline's Quarterly Profit Rises
Sarasota Herald-Tribune, FL - Jul 23, 2003
... for its products, saying its annual earnings would shine regardless of whether
generics swamped sales of its star performer, the anti-depressant Paxil. ...
Big Drugmakers Losing Sales to Rivals
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Drugmakers sales slow down due to rival medicines
Forbes - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Big Drugmakers Losing Sales to Rivals
Reuters, UK - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
Big Drugmakers Losing Sales to Rivals
MSN Money - Jul 23, 2003
... The London-based firm raised its 2003 forecast due to delays in the US launch of
generic rivals to its antidepressants, Paxil and Wellbutrin, analysts said. ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update3)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
UPDATE 4-Glaxo raises guidance after strong Q2, shares gain
Reuters, UK - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
Tactical unit ends 4-hour standoff
Lake Country Reporter, WI - Jul 23, 2003
... suffered a motorcycle accident sometime in the past, the man had been taking several
anti-anxiety and painkilling drugs through prescriptions, including Paxil ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update2)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update1)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
Glaxo 2nd-Qtr Net Rises 13% on Higher Sales of Advair (Update4)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
Glaxo 2nd-Qtr Net Rises 13% on Higher Sales of Advair (Update4)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
GlaxoSmithKline, Roche Raise Estimates on Drug Sales (Update2)
Bloomberg - Jul 23, 2003
... Sales of Glaxo's Advair asthma medicine rose 31 percent to 531 million pounds in
the quarter, while revenue from the Paxil antidepressant was unchanged at 520 ...
Patents, research keep costs high
Lorain Morning Journal, OH - Jul 23, 2003
... direct to consumers in 2000 all became blockbusters in 2001: Vioxx, Zocor, heartburn
reliever Prilosec, allergy reliever Claritin and anti-depressant Paxil. ...
Glaxo sales stall as generics bite
Business World, Ireland - Jul 23, 2003
... We now expect earnings per share growth of high single digits or better in 2003,
regardless of possible generic competition to Paxil in the US," he said. ...
Glaxo's Profit Climbs
Smart Money - Jul 23, 2003
... deliver earnings-per-share growth in the high single digits or better for all of
2003, regardless of possible generic competition to its antidepressant Paxil ...
Weak dollar hits GSK sales
BBC News, UK - Jul 23, 2003
... But sales of its top anti-depressant drug Paxil were flat at about £520m, amid
growing fears of competition from cheaper generic versions of the drug. ...
Glaxo 2nd-Qtr Net Rises 13% on Higher Sales of Advair (Update3)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
Glaxo 2nd-Qtr Net Rises 13% on Higher Sales of Advair (Update3)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
AOL Time Warner, Eastman Kodak
CBS MarketWatch - Jul 23, 2003
... percentage growth in business performance earnings per share at constant exchange
rates for the full year, regardless of possible generic competition to Paxil ...
Glaxo profit beats Q2 forecasts, raises guidance
Forbes - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
Glaxo Earns Beat Forecasts, Shares Climb
Reuters, UK - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
UPDATE 2-Glaxo Q2 earnings beat forecasts, shares climb
Reuters, UK - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
Glaxo posts 9% gain in 2Q profit
CNN/Money - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
GSK raises guidance as Q2 beats expectations
Financial Times (subscription), UK - Jul 23, 2003
... per share in 2003, in spite of losing £300m ($479m) worth of Augmentin sales in
the first half of the year and the possibility of generic competition for Paxil ...
Glaxo 2nd-Qtr Net Rose 13% on Higher Sales of Advair (Update2)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
Glaxo 2nd-Qtr Net Rose 13% on Higher Sales of Advair (Update2)
Bloomberg - Jul 23, 2003
... whose pay package was rejected by shareholders in May, was able to boost the earnings
outlook for this year by protecting patents for the antidepressants Paxil ...
Glaxo Earns Beat Forecasts, Shares Climb
Washington Post, DC - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
Glaxo Earns Beat Forecasts, Shares Climb
Reuters, UK - Jul 23, 2003
... guidance, predicting high single-digit EPS growth or better, excluding currency effects,
regardless of possible generic competition to antidepressant Paxil in ...
| Google Home - Advertise with Us - Business Solutions - Services & Tools - Jobs, Press, & Help |